Position in RNXT
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$13,013
-$398 QoQ
Shares Held
13,279
0.0% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#4
of 6 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RNXT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Affinity Capital Advisors, LLC holds $13,013 across 1 Biotechnology name. RNXT ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RNXT |
RenovoRx, Inc.
This page
|
13,279 | $13,013 |
All Filings in RNXT
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,013 | 13,279 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $13,411 | 13,279 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $11,154 | 13,279 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $16,864 | 13,279 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $17,461 | 13,279 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $13,146 | 13,279 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $17,129 | 13,279 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $14,075 | 13,279 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $15,005 | 13,279 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $17,793 | 13,279 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $30,408 | 13,279 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $17,661 | 13,279 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $30,010 | 13,279 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $46,277 | 13,279 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $35,858 | 15,259 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $22,725 | 11,250 | Shares | Sole | 2022-10-12 | |
| No filing history on record for this holder in this stock. | ||||||